Table TDI-10. Characteristics of all clients treated for drug problems: demographics and primary drug at treatment in 2002 or most recent year available. Part (i) Demographics and injecting status

Country		Year	No. of clients	Mean age	% Age <25	% Age 35+	% Male	% Injecting main drug

Belgium	⁽¹⁾	1999	10242	26	52	16	77	12
Czech Republic	⁽²⁾	2002	9237	23.4	67.9	6.8	68	64
Denmark		2002	4310	31.5	25.8	35.9	76	na
Germany	⁽⁴⁾	2002	20889	26.7	51	18	80	na
Greece		2002	3630	28.5	41.8	23.1	83.4	52.9
Spain		2002	43831	31.4	22	32	84	15
France	⁽⁵⁾	1999	16670	30.8	18.9	27.1	77	na
Ireland	⁽⁶⁾	2000	4778	25.1	56	9.9	73	42.9
Italy	⁽⁷⁾	2002	159740	32.3	16.5	37.2	86.5	na
Latvia	⁽⁸⁾	2002	2659	26.8	18.6	16	78.9	na
Lithuania		2002	4405	32.4	40.8	23	81.7	na
Luxembourg		2002	470	31.1	18	34	75	53
Hungary		2002	12777	na	36	27	59	16
Netherlands	⁽¹²⁾	2002	10403	33	21	39	83	5
Austria	⁽¹³⁾	2002	5857	33.2	17.3	44.7	70	100
Portugal	⁽¹⁴⁾	2002	31835	na	na	na	na	na
Slovenia		2002	2633	26.2	48.4	11.7	77.9	71.4
Slovakia		2002	2111	25.8	54.6	11.4	78.5	56.7
Finland		2002	3497	25.5	57.1	13.3	71	57.3
Sweden	⁽¹⁵⁾	2002	1044	33	37	35	67	21
United Kingdom	⁽¹⁶⁾	2002	40184	28.3	38.2	18.1	74	38

Notes:
		Data were not available for: Estonia, Cyprus, Malta, Poland and Norway.
Belgium	⁽¹⁾	Data refer only to outpatient treatment centres. Last data available refer to 1999.
Czech Republic	⁽²⁾	Data refer to all treatment centres.
Germany	⁽⁴⁾	Data only refer to outpatient treatment centres; information about injecting use is not available.
France	⁽⁵⁾	The last available data on treatment demand are reported, referring to the annual census on clients in treatment carried out in November 1999.
Ireland	⁽⁶⁾	Last data available refer to 2000.
Italy	⁽⁷⁾	Data only refer to outpatient treatment centres; information about injecting opiate use refers only to heroin, for cocaine only to cocaine CIH.
Latvia	⁽⁸⁾	Data refer only to outpatient treatment centres.
Netherlands	⁽¹²⁾	Data refer only to outpatient treatment centres.
Austria	⁽¹³⁾	Data refer to clients in substitution treatment only; figures for opiates as main drug and injecting use are consequently 100%.
Portugal	⁽¹⁴⁾	Coverage is limited and variable, with no control on double counting of clients.
Sweden	⁽¹⁵⁾	Data refer only to outpatient treatment centres.
United Kingdom	⁽¹⁶⁾	Data relate to the period from 1 April 2001 to 31 March 2002 for Scotland and Northern Ireland; for England and Wales six months data ending 30 September 2000 plus six months data ending 31 March 2001.

Associated graphic:
Trends in current injecting drug use amongst heroin users in treatment [Figure9OL].

Sources: 2003 Reitox national reports, Standard table 3, see [Table TDI-10 Part (iii)] for details on sources.

Download